Cite
HARVARD Citation
Chen, H. et al. (2016). Efficacy of omalizumab (Xolair®) in patients with moderate to severe predominately chronic oral steroid dependent asthma in Taiwan: a retrospective, population-based database cohort study. BMC pulmonary medicine. 16 (1), pp. 1-9. [Online].